Injection d’Oxosar 50 mg

Injection d’Oxosar 50 mg is a pharmaceutical preparation containing the active ingredient Oxaliplatin. Oxaliplatin is a platinum-based chemotherapy drug used in the treatment of various types of cancer. It works by interfering with the DNA of cancer cells, preventing them from growing and dividing. This ultimately leads to the death of cancer cells.

Injection d’Oxosar 50 mg is primarily indicated for the treatment of metastatic colorectal cancer, often in combination with other chemotherapy agents. It may also be used in other types of cancer as determined by a medical professional.

The dosage and administration of Injection d’Oxosar 50 mg will be determined by the prescribing physician based on the patient’s specific condition, response to treatment, and other individual factors. It is typically administered intravenously by a healthcare professional.

Common side effects associated with Oxaliplatin therapy can include peripheral neuropathy (numbness, tingling, or pain in the hands and feet), nausea, vomiting, diarrhea, fatigue, and myelosuppression (low blood cell counts). It is crucial to report any new or worsening symptoms to your doctor immediately.

Injection d’Oxosar 50 mg should be stored at room temperature, protected from light, and kept out of reach of children. It should only be administered under the supervision of a qualified healthcare provider.